Kelly Bryant
About Kelly Bryant
Kelly Bryant is the Human Resources Manager at Alkermes, Inc. in Dublin, Ireland, with over three decades of experience in human resources management, including 19 years in the biopharmaceutical industry.
Title and Current Company
Kelly Bryant serves as the Human Resources Manager at Alkermes, Inc. in Dublin, Ireland. In this role, she manages the human resources functions for a company that specializes in biopharmaceutical solutions, particularly for central nervous system diseases such as schizophrenia, depression, addiction, and multiple sclerosis.
Professional Experience at Alkermes
Kelly Bryant has been with Alkermes, Inc. since 2004. During her tenure, she has contributed to the company’s growth and development in the biopharmaceutical sector. Her role involves overseeing HR operations, employee relations, and talent acquisition. Bryant's extensive experience helps ensure that Alkermes maintains a robust workforce committed to advancing treatments for CNS diseases.
Prior Work Experience
Before joining Alkermes, Kelly Bryant worked at Sencorp for 16 years (1988-2004) in the United States, handling human resources duties. Before that, she served as Associate Project Director at IRI in Chicago, Illinois, from 1986 to 1988. These roles have endowed her with a rich background in HR management, underscoring her expertise and adaptability within different sectors.
Educational Background
Kelly Bryant holds a Bachelor of Arts degree in Psychology and Communications from Muskingum University, where she studied from 1981 to 1985. Her academic background laid a strong foundation for her career in human resources, equipping her with valuable skills in understanding human behavior and effective communication.
Biopharmaceutical Industry Expertise
With over 19 years of experience in the biopharmaceutical industry, Kelly Bryant brings specialized knowledge to her role at Alkermes. Her expertise includes managing human resources for a company focused on CNS diseases. This long-standing experience highlights her dedication to the field and her ability to navigate the complexities of the biopharmaceutical sector.